isoguvacine has been researched along with Hyperplasia in 1 studies
isoguvacine: A GABA agonist; RN given refers to parent cpd; structure
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Denda, M | 1 |
| Inoue, K | 1 |
| Inomata, S | 1 |
| Denda, S | 1 |
1 other study available for isoguvacine and Hyperplasia
| Article | Year |
|---|---|
gamma-Aminobutyric acid (A) receptor agonists accelerate cutaneous barrier recovery and prevent epidermal hyperplasia induced by barrier disruption.
Topics: Animals; Baclofen; Epidermis; GABA Agonists; GABA-A Receptor Agonists; Humidity; Hyperplasia; Isonic | 2002 |